These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 121529

  • 21. [Echocardiographic parameters and systolic times in arterial hypertension in the elderly].
    Pentimone F, Santoro G, Giusti C, Di Bello V, Cini G, Del Corso L.
    Minerva Cardioangiol; 1989 Sep; 37(9):369-73. PubMed ID: 2608185
    [Abstract] [Full Text] [Related]

  • 22. Systolic time intervals in hypothyroidism: end organ function as a reflection of clinical status.
    Plotnick GD, Vassar DL, Parisi AF, Hamilton BP, Carliner NH, Fisher ML.
    Am J Med Sci; 1979 Sep; 277(3):263-8. PubMed ID: 453231
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of left ventricular function in diabetics by studying systolic time intervals].
    Babalis D, Cokkinos D, Voridis E.
    Arch Mal Coeur Vaiss; 1982 Nov; 75(11):1287-90. PubMed ID: 6818919
    [Abstract] [Full Text] [Related]

  • 24. Post-exertion changes in left ventricular systolic time intervals in patients with primary hypertension treated with hydrochlorothiazide, binazine, and propranolol.
    Markiewicz K, Górski L, Cholewa M.
    Acta Med Hung; 1985 Nov; 42(3-4):153-62. PubMed ID: 4094841
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982 Nov; 12(10):729-35. PubMed ID: 7182212
    [Abstract] [Full Text] [Related]

  • 26. Effect of treatment on systolic time intervals in systemic arterial hypertension.
    Mehrotra TN, Bhatia R, Mehrotra R.
    Indian Heart J; 1989 Nov; 41(2):105-7. PubMed ID: 2526076
    [Abstract] [Full Text] [Related]

  • 27. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M, Halttunen P, Saarinen P, Sarna S.
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [Abstract] [Full Text] [Related]

  • 28. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P, Pozet N, Sassard J, Vincent M.
    Nouv Presse Med; 1980 Mar 29; 9(15):1087-90. PubMed ID: 7008020
    [Abstract] [Full Text] [Related]

  • 29. Erythrityl tetranitrate: sustained effects on systolic time intervals. changes consistent with sustained preload reduction.
    de la Paz LA, Kerigan AT, Koch GG, Kolman WA, Spodick DH.
    Am J Med Sci; 1979 Mar 29; 277(2):173-7. PubMed ID: 380340
    [Abstract] [Full Text] [Related]

  • 30. Mean electromechanical delta P/ delta t and systolic time intervals in coronary artery disease.
    Brubakk O, Følling M.
    Eur J Cardiol; 1978 Jul 29; 7(5-6):367-77. PubMed ID: 699936
    [Abstract] [Full Text] [Related]

  • 31. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ, Armstrong BK, Nassim MA, Beilin LJ.
    Br J Clin Pharmacol; 1976 Aug 29; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [Abstract] [Full Text] [Related]

  • 32. [Dynamics of left ventricular systole in primary arterial hypertension with a positive submaximal stress test].
    Markiewicz K, Cholewa M, Górski L, Gawor Z.
    Z Gesamte Inn Med; 1986 Sep 15; 41(18):497-502. PubMed ID: 2948326
    [Abstract] [Full Text] [Related]

  • 33. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A, Gamio Capestany F, Hernández-Cañero A, García-Barreto D.
    Cor Vasa; 1983 Sep 15; 25(4):233-40. PubMed ID: 6139268
    [Abstract] [Full Text] [Related]

  • 34. [Non-invasive evaluation of left ventricular function (systolic time interval) in patients using double-chamber pacemakers programmed on DDD and VVI].
    Paisana F, Providência LA, Cristóvão J, Faria H, Pêgo M, Calisto J, Morais J, Andrade C, Monteiro V, Gouveia ML.
    Rev Port Cardiol; 1989 May 15; 8(5):367-70. PubMed ID: 2631848
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL, Davies DM, Gales GM, Rao JG, Rawlins MD, Routledge PA.
    Br J Clin Pharmacol; 1979 May 15; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [Abstract] [Full Text] [Related]

  • 36. Noninvasive assessment of left ventricular function related to serum digoxin levels in neonates.
    Sandor GG, Bloom KR, Izukawa T, Patterson MW, Rowe RD.
    Pediatrics; 1980 Mar 15; 65(3):541-6. PubMed ID: 7360542
    [Abstract] [Full Text] [Related]

  • 37. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A, Allonen H, Kleimola T.
    Int J Clin Pharmacol Biopharm; 1979 Feb 15; 17(2):71-5. PubMed ID: 422304
    [Abstract] [Full Text] [Related]

  • 38. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF, Al-Khalidi A, Shaarbaf H, Tawfiq NH.
    Pharmatherapeutica; 1982 Feb 15; 3(2):133-9. PubMed ID: 7048338
    [Abstract] [Full Text] [Related]

  • 39. Cardiac performance in relation to age of onset of menopause.
    Kaur M, Singh H, Ahuja GK.
    J Indian Med Assoc; 2011 Apr 15; 109(4):234-7. PubMed ID: 22187793
    [Abstract] [Full Text] [Related]

  • 40. Pindolol and systolic time intervals in patients with hypertension.
    Hammond JJ, Kirkendall WM, Jacks-Nagle VL, Plotnick GD, Fisher ML, Hamilton JH, Robinson M, Carliner NH, Janoski AH, Hamilton BP.
    Am Heart J; 1982 Aug 15; 104(2 Pt 2):456-64. PubMed ID: 7102532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.